Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 445

1.

α-Smooth muscle actin-positive myofibroblasts, in association with epithelial-mesenchymal transition and lymphogenesis, is a critical prognostic parameter in patients with oral tongue squamous cell carcinoma.

Ding L, Zhang Z, Shang D, Cheng J, Yuan H, Wu Y, Song X, Jiang H.

J Oral Pathol Med. 2014 May;43(5):335-43. doi: 10.1111/jop.12143. Epub 2013 Dec 9.

PMID:
24313357
2.

A role for cancer-associated fibroblasts in inducing the epithelial-to-mesenchymal transition in human tongue squamous cell carcinoma.

Zhou B, Chen WL, Wang YY, Lin ZY, Zhang DM, Fan S, Li JS.

J Oral Pathol Med. 2014 Sep;43(8):585-92. doi: 10.1111/jop.12172. Epub 2014 Mar 20.

PMID:
24645915
3.

Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma.

Wang C, Huang H, Huang Z, Wang A, Chen X, Huang L, Zhou X, Liu X.

J Oral Pathol Med. 2011 Aug;40(7):545-51. doi: 10.1111/j.1600-0714.2011.01041.x. Epub 2011 Apr 12.

4.

T-box transcription factor Brachyury expression is correlated with epithelial-mesenchymal transition and lymph node metastasis in oral squamous cell carcinoma.

Imajyo I, Sugiura T, Kobayashi Y, Shimoda M, Ishii K, Akimoto N, Yoshihama N, Kobayashi I, Mori Y.

Int J Oncol. 2012 Dec;41(6):1985-95. doi: 10.3892/ijo.2012.1673. Epub 2012 Oct 17.

5.

Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.

Kono M, Watanabe M, Abukawa H, Hasegawa O, Satomi T, Chikazu D.

J Oral Maxillofac Surg. 2013 Oct;71(10):1694-702. doi: 10.1016/j.joms.2013.04.015. Epub 2013 Jul 1.

PMID:
23809761
6.

Blocking PI3K/Akt signaling attenuates metastasis of nasopharyngeal carcinoma cells through induction of mesenchymal-epithelial reverting transition.

Jiang H, Gao M, Shen Z, Luo B, Li R, Jiang X, Ding R, Ha Y, Wang Z, Jie W.

Oncol Rep. 2014 Aug;32(2):559-66. doi: 10.3892/or.2014.3220. Epub 2014 May 29.

PMID:
24889918
7.

[Association between lymphangiogenesis and clinicopathological features and prognosis in laryngeal carcinoma].

Zou JD, Fu HY, Xu W, Lü ZH, Cao HY, Luan XY.

Zhonghua Zhong Liu Za Zhi. 2011 Jun;33(6):461-4. Chinese.

PMID:
21875489
8.

Perineural invasion and expression of nerve growth factor can predict the progression and prognosis of oral tongue squamous cell carcinoma.

Shen WR, Wang YP, Chang JY, Yu SY, Chen HM, Chiang CP.

J Oral Pathol Med. 2014 Apr;43(4):258-64.

PMID:
24822265
9.

Role of stromal myofibroblasts in invasive breast cancer: stromal expression of alpha-smooth muscle actin correlates with worse clinical outcome.

Yamashita M, Ogawa T, Zhang X, Hanamura N, Kashikura Y, Takamura M, Yoneda M, Shiraishi T.

Breast Cancer. 2012 Apr;19(2):170-6. doi: 10.1007/s12282-010-0234-5. Epub 2010 Oct 27.

PMID:
20978953
10.

ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.

Ma Y, Zheng X, Zhou J, Zhang Y, Chen K.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):11258-67. eCollection 2015.

11.

Single cell migration in oral squamous cell carcinoma - possible evidence of epithelial-mesenchymal transition in vivo.

Jensen DH, Reibel J, Mackenzie IC, Dabelsteen E.

J Oral Pathol Med. 2015 Oct;44(9):674-9. doi: 10.1111/jop.12321. Epub 2015 Apr 16.

PMID:
25880532
12.

Expression of epithelial-mesenchymal transition markers at the invasive front of oral squamous cell carcinoma.

Costa LC, Leite CF, Cardoso SV, Loyola AM, Faria PR, Souza PE, Horta MC.

J Appl Oral Sci. 2015 Mar-Apr;23(2):169-78. doi: 10.1590/1678-775720140187.

13.

Vimentin expression of esophageal squamous cell carcinoma and its aggressive potential for lymph node metastasis.

Jin H, Morohashi S, Sato F, Kudo Y, Akasaka H, Tsutsumi S, Ogasawara H, Miyamoto K, Wajima N, Kawasaki H, Hakamada K, Kijima H.

Biomed Res. 2010 Apr;31(2):105-12.

14.

Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue.

Lim SC, Zhang S, Ishii G, Endoh Y, Kodama K, Miyamoto S, Hayashi R, Ebihara S, Cho JS, Ochiai A.

Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):166-72.

15.

Prognostic value of LYVE-1-positive lymphatic vessel in tongue squamous cell carcinomas.

Matsumoto N, Mukae S, Tsuda H, Sawada A, Okazaki Y, Nagai K, Akishima-Fukasawa Y, Ohki H, Ishikawa Y, Ishii T, Komiyama K.

Anticancer Res. 2010 Jun;30(6):1897-903.

PMID:
20651332
16.

Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis.

Wei Z, Wang Y, Li Z, Yuan C, Zhang W, Wang D, Ye J, Jiang H, Wu Y, Cheng J.

J Oral Pathol Med. 2013 Nov;42(10):747-54. doi: 10.1111/jop.12062. Epub 2013 Mar 29.

PMID:
23551691
17.

Vimentin is a potential prognostic factor for tongue squamous cell carcinoma among five epithelial-mesenchymal transition-related proteins.

Liu PF, Kang BH, Wu YM, Sun JH, Yen LM, Fu TY, Lin YC, Liou HH, Lin YS, Sie HC, Hsieh IC, Tseng YK, Shu CW, Hsieh YD, Ger LP.

PLoS One. 2017 Jun 1;12(6):e0178581. doi: 10.1371/journal.pone.0178581. eCollection 2017.

18.

Clinical significance of lymphatic and blood vessel invasion in oral tongue squamous cell carcinomas.

Michikawa C, Uzawa N, Kayamori K, Sonoda I, Ohyama Y, Okada N, Yamaguchi A, Amagasa T.

Oral Oncol. 2012 Apr;48(4):320-4. doi: 10.1016/j.oraloncology.2011.11.014. Epub 2011 Dec 16.

PMID:
22178206
19.

Aberrant expression of nuclear vimentin and related epithelial-mesenchymal transition markers in nasopharyngeal carcinoma.

Luo W, Fang W, Li S, Yao K.

Int J Cancer. 2012 Oct 15;131(8):1863-73. doi: 10.1002/ijc.27467. Epub 2012 Mar 15.

20.

Epithelial-mesenchymal Transition (EMT) is Correlated with Patient's Prognosis of Lung Squamous Cell Carcinoma.

Aruga N, Kijima H, Masuda R, Onozawa H, Yoshizawa T, Tanaka M, Inokuchi S, Iwazaki M.

Tokai J Exp Clin Med. 2018 Apr 20;43(1):5-13.

Supplemental Content

Support Center